Hemophilia Market
Hemophilia Market - Global Industry Assessment & Forecast
#
Pages:
183
Base Year:
2022
Jan - 2022
Format:
Report Code:
VMR-1216
Segments Covered
By
Type Hemophilia A, Hemophilia B, Hemophilia C, Others
-
By
Treatment On-demand, Prophylaxis
-
By
Therapy Replacement therapy, ITI therapy, Gene therapy
-
By
Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 12.61 Billion |
 Revenue 2030:
|
USD 18.77 Billion |
 Revenue CAGR
(2023 - 2030): |
5.10% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Hemophilia Market Segment Analysis
- Hemophilia Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Hemophilia Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- On-demand
- Prophylaxis
- Hemophilia Therapy Outlook (Revenue, USD Million, 2018 - 2030)
- Replacement therapy
- ITI therapy
- Gene therapy
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
-
North America Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
-
North America Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- U.S.
- U.S. Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- U.S. Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- U.S. Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- U.S. Hemophilia Market, by Type
- Canada
- Canada Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Canada Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Canada Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Canada Hemophilia Market, by Type
-
Mexico
- Mexico Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Mexico Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Mexico Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Mexico Hemophilia Market, by Type
-
North America Hemophilia Market, by Type
- Europe
-
Europe Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
-
Europe Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
-
Europe Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- U. K.
- U.K. Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- U.K. Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- U.K. Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- U.K. Hemophilia Market, by Type
- France
- France Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- France Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- France Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- France Hemophilia Market, by Type
-
Germany
- Germany Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Germany Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Germany Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Germany Hemophilia Market, by Type
-
Italy
- Italy Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Italy Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Italy Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Italy Hemophilia Market, by Type
-
Spain
- Spain Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Spain Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Spain Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Spain Hemophilia Market, by Type
-
Rest of Europe
- Rest of Europe Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Rest of Europe Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Rest of Europe Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Rest of Europe Hemophilia Market, by Type
-
Europe Hemophilia Market, by Type
- Asia Pacific
-
Asia Pacific Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
-
Asia Pacific Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
-
Asia Pacific Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- China
- China Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- China Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- China Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- China Hemophilia Market, by Type
- Japan
- Japan Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Japan Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Japan Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Japan Hemophilia Market, by Type
-
Germany
- Germany Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Germany Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Germany Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Germany Hemophilia Market, by Type
-
India
- India Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- India Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- India Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- India Hemophilia Market, by Type
-
South Korea
- South Korea Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- South Korea Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- South Korea Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- South Korea Hemophilia Market, by Type
-
South East Asia
- South East Asia Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- South East Asia Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- South East Asia Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- South East Asia Hemophilia Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Rest of Asia Pacific Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Rest of Asia Pacific Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Rest of Asia Pacific Hemophilia Market, by Type
-
Asia Pacific Hemophilia Market, by Type
- Latin America
-
Latin America Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
-
Latin America Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
-
Latin America Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Brazil
- Brazil Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Brazil Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Brazil Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Brazil Hemophilia Market, by Type
- Argentina
- Argentina Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Argentina Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Argentina Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Argentina Hemophilia Market, by Type
-
Rest of Latin America
- Rest of Latin America Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Rest of Latin America Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Rest of Latin America Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Rest of Latin America Hemophilia Market, by Type
-
Latin America Hemophilia Market, by Type
- Middle East & Africa
-
Middle East & Africa Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
-
Middle East & Africa Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
-
Middle East & Africa Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- GCC Countries
- GCC Countries Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- GCC Countries Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- GCC Countries Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- GCC Countries Hemophilia Market, by Type
- South Africa
- South Africa Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- South Africa Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- South Africa Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- South Africa Hemophilia Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Hemophilia Market, by Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
- Others
- Rest of Middle East & Africa Hemophilia Market, by Treatment
- On-demand
- Prophylaxis
- Rest of Middle East & Africa Hemophilia Market, by Therapy
- Replacement therapy
- ITI therapy
- Gene therapy
- Rest of Middle East & Africa Hemophilia Market, by Type
-
Middle East & Africa Hemophilia Market, by Type
- North America
Vantage Market
Research | 30-Jan-2022
FAQ
Frequently Asked Question
What is the global demand for Hemophilia in terms of revenue?
-
The global Hemophilia valued at USD 12.61 Billion in 2022 and is expected to reach USD 18.77 Billion in 2030 growing at a CAGR of 5.10%.
Which are the prominent players in the market?
-
The prominent players in the market are Shire (Baxalta); CSL Behring; Pfizer, Inc.; Bayer AG; BioMarin, Spark Therapeutics, Inc.; Genzyme Corporation; Chugai Pharmaceutical Co. Ltd.; Novo Nordisk A/S.; and Octapharma AG.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 5.10% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Hemophilia include
- Growing Prevalence of Hemophilia
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Hemophilia in 2022.
